Figure 2.
Anisomycin (AN) suppressed HCC cell migration through the p38 MAPK pathway. AN suppressed HCC cell migration (a) and healing ability (b). The effect was evaluated by transwell and wound-healing assay. SB203580 (SB) was used to rescue cells from AN treatment. N = 3; ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. (c) The expression levels of epithelial-mesenchymal transition-related proteins in AN treatment (24 h).